Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump.
We describe the successful use of the Impella LP 5.0 intracardiac microaxial pump (Abiomed, Danvers, MA) in a 13-year-old boy with fulminant biopsy-proven viral myocarditis. The patient, who previously was in refractory cardiogenic shock despite increasing inotropic and vasopressor support, immediately stabilized after Impella LP 5.0 implantation and was successfully bridged to a full recovery. Months later, he remains completely well, with no intracardiac or peripheral vascular sequelae of the procedure. In carefully selected pediatric patients the Impella may be a beneficial form of temporary mechanical circulatory support for fulminant cardiogenic shock.
Andrade
Jason G
JG
Division of Cardiology, University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada. jasonandrade@shaw.ca
Al-Saloos
Hesham
H
Jeewa
Aamir
A
Sandor
George G S
GG
Cheung
Anson
A
D000293:Adolescent; D000367:Age Factors; D006321:Heart / Q000502:physiology*; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D009205:Myocarditis / Q000150:complications / Q000601:surgery* / Q000821:virology*; D020127:Recovery of Function / Q000502:physiology; D012770:Shock, Cardiogenic / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D013318:Stroke Volume / Q000502:physiology; D016896:Treatment Outcome